Standout Papers

Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer 2018 2026 2020 2023 370
  1. Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer (2018)
    Yi-Mi Wu, Marcin Cieślik et al. Cell

Immediate Impact

4 by Nobel laureates 6 from Science/Nature 53 standout
Sub-graph 1 of 20

Citing Papers

The hallmarks of cancer immune evasion
2024 Standout
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
2024 StandoutNature
3 intermediate papers

Works of Lisha Wang being referenced

Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
2018 Standout

Author Peers

Author Last Decade Papers Cites
Lisha Wang 124 292 166 273 14 526
Linda Mahjoubi 111 362 207 203 12 543
Coraline Duménil 128 416 122 228 20 533
Ze-Qin Guo 125 302 286 211 14 575
Tianqiang Jin 233 278 227 132 19 626
Dan Sha 106 347 196 200 16 599
Emily S. Chambers 84 302 146 269 16 540
Gemma Toledo 49 187 321 174 22 631
Betsy Morrow 54 177 118 199 18 479
Zahra Asgari 49 308 198 107 16 517
Bernadette Reyna Asuncion 173 412 146 296 16 639

All Works

Loading papers...

Rankless by CCL
2026